Literature DB >> 27411439

Environmental factors in the etiology of type 1 diabetes, celiac disease, and narcolepsy.

Åke Lernmark1.   

Abstract

The etiology of human leukocyte antigen (HLA)-associated organ-specific autoimmune diseases is incomplete. In type 1 diabetes and celiac disease, the strongest associations are with the HLA-DR3-DQ2 and DR4-DQ8 haplotypes, whereas the DQB1*06:02 allele has a strong negative association. In contrast, narcolepsy, especially as recently triggered by the Pandemrix(®) H1N1 vaccine (GlaxoKlineSmith (GSK), Brentford, Middlesex, UK), did not seem to develop without at least one copy of the latter allele. The overall hypothesis is that the role of these different HLA haplotypes, especially in Finland and Sweden, is related to the immune response to infectious agents that are common in these two populations. The high incidence of both type 1 diabetes and celiac disease in Scandinavia may be the result of the HLA-DR3-DQ2 and DR4-DQ8 haplotypes, and the DQB1*06:02 allele are common because they protected people from succumbing to common infections. The timing of dissecting the autoimmune response is critical to understand the possible role of environmental factors. First, an etiological trigger may be a common virus infecting beta cells or with antigens inducing beta-cell cross reactivity. Second, an autoimmune reaction may ensue, perhaps in response to beta-cell apoptosis or autophagy, resulting in autoantigen-specific T cells and autoantibodies. It is critical in at-risk children to dissect the immune response prior to the appearance of autoantibodies in order to identify cellular reactions in response to environmental factors that are able to induce an HLA-associated immune reaction.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  GAD65; HLA; IA-2; ZnT8 transporter; autoantigen; immune reaction; insulin; narcolepsy; tissue transglutaminase

Mesh:

Substances:

Year:  2016        PMID: 27411439      PMCID: PMC5473290          DOI: 10.1111/pedi.12390

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  48 in total

1.  Population-based genetic screening for the estimation of Type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci.

Authors:  S Nejentsev; M Sjöroos; T Soukka; M Knip; O Simell; T Lövgren; J Ilonen
Journal:  Diabet Med       Date:  1999-12       Impact factor: 4.359

2.  The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study.

Authors:  Jeffrey P Krischer; Kristian F Lynch; Desmond A Schatz; Jorma Ilonen; Åke Lernmark; William A Hagopian; Marian J Rewers; Jin-Xiong She; Olli G Simell; Jorma Toppari; Anette-G Ziegler; Beena Akolkar; Ezio Bonifacio
Journal:  Diabetologia       Date:  2015-02-10       Impact factor: 10.122

Review 3.  Genetics of type 1A diabetes.

Authors:  Patrick Concannon; Stephen S Rich; Gerald T Nepom
Journal:  N Engl J Med       Date:  2009-04-16       Impact factor: 91.245

4.  Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up.

Authors:  I Persson; F Granath; J Askling; J F Ludvigsson; T Olsson; N Feltelius
Journal:  J Intern Med       Date:  2013-11-10       Impact factor: 8.989

5.  Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia.

Authors:  Ezio Bonifacio; Liping Yu; Alastair K Williams; George S Eisenbarth; Polly J Bingley; Santica M Marcovina; Kerstin Adler; Anette G Ziegler; Patricia W Mueller; Desmond A Schatz; Jeffrey P Krischer; Michael W Steffes; Beena Akolkar
Journal:  J Clin Endocrinol Metab       Date:  2010-05-05       Impact factor: 5.958

6.  Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial.

Authors:  Kirsti Näntö-Salonen; Antti Kupila; Satu Simell; Heli Siljander; Tiina Salonsaari; Anne Hekkala; Sari Korhonen; Risto Erkkola; Jukka I Sipilä; Lotta Haavisto; Marja Siltala; Juhani Tuominen; Jari Hakalax; Heikki Hyöty; Jorma Ilonen; Riitta Veijola; Tuula Simell; Mikael Knip; Olli Simell
Journal:  Lancet       Date:  2008-09-22       Impact factor: 79.321

7.  Analysis of HLA and non-HLA alleles can identify individuals at high risk for celiac disease.

Authors:  Jihane Romanos; Cleo C van Diemen; Ilja M Nolte; Gosia Trynka; Alexandra Zhernakova; Jingyuan Fu; Maria Teresa Bardella; Donatella Barisani; Ross McManus; David A van Heel; Cisca Wijmenga
Journal:  Gastroenterology       Date:  2009-05-18       Impact factor: 22.682

8.  The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants.

Authors:  William A Hagopian; Henry Erlich; Ake Lernmark; Marian Rewers; Anette G Ziegler; Olli Simell; Beena Akolkar; Robert Vogt; Alan Blair; Jorma Ilonen; Jeffrey Krischer; JinXiong She
Journal:  Pediatr Diabetes       Date:  2011-05-12       Impact factor: 3.409

9.  Effects of Gluten Intake on Risk of Celiac Disease: A Case-Control Study on a Swedish Birth Cohort.

Authors:  Carin Andrén Aronsson; Hye-Seung Lee; Sibylle Koletzko; Ulla Uusitalo; Jimin Yang; Suvi M Virtanen; Edwin Liu; Åke Lernmark; Jill M Norris; Daniel Agardh
Journal:  Clin Gastroenterol Hepatol       Date:  2015-11-25       Impact factor: 13.576

10.  The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes.

Authors:  Spiros Fourlanos; Michael D Varney; Brian D Tait; Grant Morahan; Margo C Honeyman; Peter G Colman; Leonard C Harrison
Journal:  Diabetes Care       Date:  2008-05-16       Impact factor: 19.112

View more
  6 in total

Review 1.  Zonulin as a potential putative biomarker of risk for shared type 1 diabetes and celiac disease autoimmunity.

Authors:  Lauren K Wood Heickman; Mark D DeBoer; Alessio Fasano
Journal:  Diabetes Metab Res Rev       Date:  2020-03-31       Impact factor: 4.876

2.  A total-population multigenerational family clustering study of autoimmune diseases in obsessive-compulsive disorder and Tourette's/chronic tic disorders.

Authors:  D Mataix-Cols; E Frans; A Pérez-Vigil; R Kuja-Halkola; C Gromark; K Isomura; L Fernández de la Cruz; E Serlachius; J F Leckman; J J Crowley; C Rück; C Almqvist; P Lichtenstein; H Larsson
Journal:  Mol Psychiatry       Date:  2017-11-14       Impact factor: 15.992

3.  Live enteroviruses, but not other viruses, detected in human pancreas at the onset of type 1 diabetes in the DiViD study.

Authors:  Lars Krogvold; Angelo Genoni; Anna Puggioni; Daniela Campani; Sarah J Richardson; Christine S Flaxman; Bjørn Edwin; Trond Buanes; Knut Dahl-Jørgensen; Antonio Toniolo
Journal:  Diabetologia       Date:  2022-08-12       Impact factor: 10.460

Review 4.  The potential role for infections in the pathogenesis of autoimmune Addison's disease.

Authors:  A Hellesen; E Bratland
Journal:  Clin Exp Immunol       Date:  2018-09-30       Impact factor: 4.330

Review 5.  An Overview of Celiac Disease in Childhood Type 1 Diabetes.

Authors:  Iraj Shahramian; Ali Bazi; Alireza Sargazi
Journal:  Int J Endocrinol Metab       Date:  2018-06-27

6.  Long-Term Outcome of a Series of Patients With Narcolepsy Type 1 and Comorbidity With Immunopathological and Autoimmune Diseases.

Authors:  Francisco J Martinez-Orozco; Miguel Fernandez-Arquero; Jose L Vicario; Laura Lillo-Triguero; Elena Ameyugo; Rosa Peraita-Adrados
Journal:  J Clin Med Res       Date:  2022-08-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.